Quantedge Capital Pte Ltd Trims Stock Position in BlackRock Health Sciences Term Trust (NYSE:BMEZ)

Quantedge Capital Pte Ltd cut its stake in shares of BlackRock Health Sciences Term Trust (NYSE:BMEZ) by 42.8% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 88,854 shares of the company’s stock after selling 66,511 shares during the period. Quantedge Capital Pte Ltd’s holdings in BlackRock Health Sciences Term Trust were worth $1,279,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in the stock. Estabrook Capital Management purchased a new stake in BlackRock Health Sciences Term Trust during the 4th quarter valued at approximately $35,000. Blue Bell Private Wealth Management LLC raised its stake in BlackRock Health Sciences Term Trust by 1.8% during the 4th quarter. Blue Bell Private Wealth Management LLC now owns 186,084 shares of the company’s stock valued at $2,680,000 after acquiring an additional 3,352 shares during the last quarter. Commonwealth Equity Services LLC increased its position in BlackRock Health Sciences Term Trust by 3.7% during the 4th quarter. Commonwealth Equity Services LLC now owns 102,437 shares of the company’s stock worth $1,475,000 after purchasing an additional 3,635 shares during the period. Corient Private Wealth LLC increased its position in BlackRock Health Sciences Term Trust by 24.9% during the 4th quarter. Corient Private Wealth LLC now owns 26,225 shares of the company’s stock worth $378,000 after purchasing an additional 5,224 shares during the period. Finally, Brown Lisle Cummings Inc. increased its position in BlackRock Health Sciences Term Trust by 17.0% during the 4th quarter. Brown Lisle Cummings Inc. now owns 42,711 shares of the company’s stock worth $615,000 after purchasing an additional 6,198 shares during the period.

BlackRock Health Sciences Term Trust Trading Up 0.7%

NYSE BMEZ opened at $14.52 on Thursday. The business’s 50 day moving average is $14.41 and its two-hundred day moving average is $15.18. BlackRock Health Sciences Term Trust has a 12-month low of $12.58 and a 12-month high of $16.75.

BlackRock Health Sciences Term Trust Cuts Dividend

The firm also recently announced a monthly dividend, which will be paid on Friday, May 30th. Shareholders of record on Thursday, May 15th will be given a dividend of $0.1712 per share. This represents a $2.05 annualized dividend and a yield of 14.15%. The ex-dividend date of this dividend is Thursday, May 15th.

BlackRock Health Sciences Term Trust Profile

BlackRock Health Sciences Trust II’s (BMEZ) (the ‘Trust’) investment objective is to provide total return and income through a combination of current income, current gains and long-term capital appreciation. The Trust seeks to achieve its investment objective by investing, under normal market conditions, at least 80% of its total assets in equity securities of companies principally engaged in the health sciences group of industries and equity derivatives with exposure to the health sciences group of industries.